These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 21371594)

  • 1. Binding site identification and structure determination of protein-ligand complexes by NMR a semiautomated approach.
    Ziarek JJ; Peterson FC; Lytle BL; Volkman BF
    Methods Enzymol; 2011; 493():241-75. PubMed ID: 21371594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-ligand structure determination with the NMR molecular replacement tool, NMR
    Orts J; Riek R
    J Biomol NMR; 2020 Nov; 74(10-11):633-642. PubMed ID: 32621003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast Quantitative Validation of 3D Models of Low-Affinity Protein-Ligand Complexes by STD NMR Spectroscopy.
    Nepravishta R; Ramírez-Cárdenas J; Rocha G; Walpole S; Hicks T; Monaco S; Muñoz-García JC; Angulo J
    J Med Chem; 2024 Jun; 67(12):10025-10034. PubMed ID: 38848103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR in drug discovery: A practical guide to identification and validation of ligands interacting with biological macromolecules.
    Gossert AD; Jahnke W
    Prog Nucl Magn Reson Spectrosc; 2016 Nov; 97():82-125. PubMed ID: 27888841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR spectroscopy: the swiss army knife of drug discovery.
    Horst R; Farley KA; Kormos BL; Withka JM
    J Biomol NMR; 2020 Nov; 74(10-11):509-519. PubMed ID: 32617727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol to perform fragment screening using NMR spectroscopy.
    Huang Q; Kang C
    STAR Protoc; 2024 Sep; 5(3):103278. PubMed ID: 39178109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates.
    Angulo J; Enríquez-Navas PM; Nieto PM
    Chemistry; 2010 Jul; 16(26):7803-12. PubMed ID: 20496354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR approaches in structure-based lead discovery: recent developments and new frontiers for targeting multi-protein complexes.
    Dias DM; Ciulli A
    Prog Biophys Mol Biol; 2014; 116(2-3):101-12. PubMed ID: 25175337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR studies of ligand binding.
    Nitsche C; Otting G
    Curr Opin Struct Biol; 2018 Feb; 48():16-22. PubMed ID: 29017071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery.
    Moore JM
    Biopolymers; 1999; 51(3):221-43. PubMed ID: 10516573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current NMR Techniques for Structure-Based Drug Discovery.
    Sugiki T; Furuita K; Fujiwara T; Kojima C
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29329228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of NMR in leveraging dynamics and entropy in drug design.
    Dubey A; Takeuchi K; Reibarkh M; Arthanari H
    J Biomol NMR; 2020 Nov; 74(10-11):479-498. PubMed ID: 32720098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paramagnetic NMR in drug discovery.
    Softley CA; Bostock MJ; Popowicz GM; Sattler M
    J Biomol NMR; 2020 Jul; 74(6-7):287-309. PubMed ID: 32524233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR-Based Determination of the 3D Structure of the Ligand-Protein Interaction Site without Protein Resonance Assignment.
    Orts J; Wälti MA; Marsh M; Vera L; Gossert AD; Güntert P; Riek R
    J Am Chem Soc; 2016 Apr; 138(13):4393-400. PubMed ID: 26943491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR Reporter Assays for the Quantification of Weak-Affinity Receptor-Ligand Interactions.
    Almeida TB; Panova S; Walser R
    SLAS Discov; 2021 Sep; 26(8):1020-1028. PubMed ID: 33899548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR-based methods and strategies for drug discovery.
    Salvatella X; Giralt E
    Chem Soc Rev; 2003 Nov; 32(6):365-72. PubMed ID: 14671791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Practical Perspective on the Roles of Solution NMR Spectroscopy in Drug Discovery.
    Li Q; Kang C
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32605297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.